tiprankstipranks
pc:antag

Antag Therapeutics

Blegdamsvej 3b Copenhagen, Nørrebro 2200, DK
https://www.antagtherapeutics.com/
Antag Therapeutics is a biopharmaceutical company focused on developing innovative treatments for obesity. The company is advancing its clinical pipeline with AT-7687, a novel, once-weekly subcutaneous therapy that targets the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) to aid in weight loss. Based in Copenhagen, Denmark, Antag Therapeutics is committed to expanding its portfolio of injectable therapies to address metabolic disorders.

Leadership & Board

Current Number of Employees22
Current LinkedIn Followers4,081

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$164M
Total Amount Raised$164M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$80M
Latest Funding Amount$80M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Antag Therapeutics had 22 employees as of April 6, 2026. The number of employees increased by 0 (0.00%) week-over-week.
22Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Antag Therapeutics had 4,081 followers as of April 6, 2026. The number of followers increased by 6 (0.15%) week-over-week.
4,081Latest Followers Count
6(0.15%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series A
$80.00M
Jan 04, 2025
Series A
$84.10M

Investors

Investor Name
Funding Round

Related News and Analysis